Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Free Cash Flow (2016 - 2025)

Prestige Consumer Healthcare has reported Free Cash Flow over the past 16 years, most recently at $75.3 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $75.3 million for Q4 2025, up 18.47% from a year ago — trailing twelve months through Dec 2025 was $267.2 million (up 7.44% YoY), and the annual figure for FY2025 was $243.3 million, up 1.64%.
  • Free Cash Flow for Q4 2025 was $75.3 million at Prestige Consumer Healthcare, up from $55.4 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PBH hit a ceiling of $78.2 million in Q2 2025 and a floor of $46.6 million in Q2 2023.
  • Median Free Cash Flow over the past 5 years was $59.0 million (2021), compared with a mean of $60.9 million.
  • Biggest five-year swings in Free Cash Flow: surged 47.29% in 2021 and later fell 18.51% in 2023.
  • Prestige Consumer Healthcare's Free Cash Flow stood at $64.1 million in 2021, then dropped by 17.06% to $53.1 million in 2022, then surged by 30.74% to $69.5 million in 2023, then fell by 8.57% to $63.5 million in 2024, then increased by 18.47% to $75.3 million in 2025.
  • The last three reported values for Free Cash Flow were $75.3 million (Q4 2025), $55.4 million (Q3 2025), and $78.2 million (Q2 2025) per Business Quant data.